Regen BioPharma Inc (RGBP)

[cvinvestor]

Sage, if Christine Ichim is employed full time with RGBP and is working on the cure for leukemia and other cancers, why would I want her to spend time possibly developing an application for non human use at this point.

The only credible argument would be that this "licensed IP" is actually possibly linked to the current pipeline products in a way that they see huge potential.

But if so, why not keep it as part of RGBP IP instead of giving "exclusive" rights to Zander? As I say, the only legitimate move here that I can even imagine is that this IP needs validation in animal testing first before RGBP could use in human application and having Zander do the testing keeps it in house, but with RGBP hopefully making progress on various fronts, I don't know why they wouldn't keep this IP as something for RGBP to develop and build on its own momentum.

Multiplying psuedo companies to spin shares all under the name and fist of one person, Koos, does not build investor confidence, especially with the licensing a cover for Koos to issue more shares.